Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

"In my experience, 70% of dogs see dramatic improvements in their stiffness and lameness" after Librela injections, a ...

Lumbosacral Radicular Pain Management MarketThe global lumbosacral radicular pain management market is poised for significant ...